Semaglutide Weight Loss Dosage Chart: Your Complete Titration Guide

Everyone seems to know someone who's lost serious weight on semaglutide. It's moved from niche obesity medicine into mainstream conversation faster than almost any drug in recent memory. And with that speed comes a lot of confusion — especially around dosing. How much do you start with? When do you go up? What happens if you miss a shot? And why does the schedule seem to take so long?

This guide cuts through the noise. Below you'll find a complete semaglutide weight loss dosage chart, a plain-English explanation of the titration schedule, and honest answers to the questions that actually matter — including when the standard protocol might not be right for you.

Whether you're just starting to research this or you're already mid-protocol and second-guessing your dose, here's what you need to know.

What Is Semaglutide, Really?

Semaglutide is a GLP-1 receptor agonist (GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat). The drug mimics that hormone, telling your brain you're full, slowing the rate at which your stomach empties, and reducing the appetite signals that make overeating so easy. It was originally developed to treat type 2 diabetes under the brand name Ozempic, then approved at higher doses for chronic weight management under the brand name Wegovy.

Think of it less like a fat-burner and more like a volume knob for hunger. You're not burning more calories — you're just not relentlessly fighting the urge to consume more of them. For a lot of people, that's the missing piece.

The reason dosing matters so much is that semaglutide's side effects — nausea, vomiting, GI discomfort — are highly dose-dependent. Start too high and you'll feel terrible. Titrate too fast and the same thing happens. The slow escalation schedule isn't bureaucratic caution; it's genuinely the difference between tolerating the drug and quitting it by week three.

Semaglutide Weight Loss Dosage Chart

The FDA-approved titration schedule for semaglutide (Wegovy) for weight loss follows a predictable escalation over approximately 16-20 weeks. Here's the standard protocol at a glance:

That 2.4 mg/week maintenance dose is the FDA-approved target for weight loss. It's where the landmark STEP 1 trial showed participants losing an average of 14.9% of their body weight over 68 weeks — roughly three times the weight loss seen with lifestyle intervention alone.

One important note: the 0.25 mg starting dose is intentional and non-negotiable. It's not a "therapeutic" dose for weight loss — it's a tolerance-building dose. Rushing past it doesn't get you results faster; it mostly gets you nausea.

How Semaglutide Titration Actually Works

Why the escalation schedule exists

Semaglutide has a half-life of approximately one week, which is why it's dosed weekly. But that long half-life also means it accumulates in your system over time. Each dose increase builds on the previous one, and your GI system needs time to adapt to rising drug levels. The four-week intervals between dose increases aren't arbitrary — they give your body enough time to reach a new steady-state concentration before you push higher.

Here's the catch: the standard schedule is a floor, not a ceiling. If you're experiencing significant nausea or GI side effects at a given dose, it's clinically appropriate to stay at that dose longer before escalating. Rushing the schedule to hit 2.4 mg faster is one of the most common reasons people drop out.

When dose escalation should pause

Your prescriber may recommend extending any dose level by four additional weeks (or longer) if you're experiencing:

• Nausea severe enough to affect daily function
• Frequent vomiting or diarrhea
• Significant loss of appetite beyond what's expected
• Any new symptoms you haven't discussed with your clinical team

Slower titration isn't failure — it's often the reason people actually stick with the drug long enough to see meaningful results.

Injection Timing: When and Where to Inject

When during the week?

Semaglutide is injected once weekly, and you can take it on any day of the week. The main rule: pick a day and stick to it. The drug's seven-day half-life means consistency in timing keeps your blood levels stable. Many people choose a weekend day when they're less likely to forget and more able to manage any mild GI effects that follow the injection.

Does food timing matter?

Unlike some GLP-1 medications, semaglutide (in injectable form) doesn't need to be taken with or without food. You can inject at any time of day, regardless of meals. That said, some people report slightly less nausea when injecting in the evening, since they sleep through the peak absorption window. Experiment with timing in the first few weeks and find what works for your routine.

Injection site rotation

Semaglutide is injected subcutaneously (just under the skin) in the abdomen, thigh, or upper arm. Rotating injection sites within these areas reduces the risk of localized skin irritation or lipodystrophy (small lumps or indentations from repeated injections in the same spot). Don't inject into the same spot twice in a row.

What to Do If You Miss a Dose

This comes up constantly, and the answer is simpler than most people expect:

• If it's been less than 5 days since your missed dose: Take it as soon as you remember, then resume your regular weekly schedule.
• If it's been 5 days or more: Skip the missed dose entirely. Take your next dose on your regularly scheduled day. Don't double up.
• If you're not sure: Call your prescriber. Always. Don't guess with this one.

Missing an occasional dose isn't catastrophic — semaglutide's long half-life provides some buffer. But regularly missed doses will blunt your results and can make side effects worse when you restart, because your system partially de-adapts between injections.

What the Evidence Actually Shows

The weight loss data for semaglutide at 2.4 mg/week is genuinely compelling. Here's what the research shows:

• STEP 1 trial: Adults with obesity (no diabetes) lost an average of 14.9% of body weight over 68 weeks versus 2.4% with placebo. Nearly 70% lost at least 10% of their body weight.
• STEP 4 trial: Participants who continued semaglutide maintained their weight loss, while those who switched to placebo regained roughly two-thirds of the weight they'd lost within a year. This is the "you'll need to stay on it" conversation your doctor should be having with you.
• SELECT trial (2023): In adults with cardiovascular disease and obesity (but no diabetes), semaglutide at 2.4 mg/week reduced major cardiovascular events by 20% versus placebo — independent of weight loss. That's not a small finding.
• Glycemic effects: Even in people without diabetes, semaglutide meaningfully improves fasting glucose, insulin sensitivity, and HbA1c — suggesting metabolic benefits that go beyond the number on the scale.

The internet wants this to be a magic shot. The research is more honest than that: it works well, for most people, when used consistently, at therapeutic doses, with appropriate lifestyle context. It doesn't work forever without ongoing use. And it doesn't replace the basics.

The Reality Check

A few things worth being clear about:

First, most of the long-term data comes from trials lasting one to two years. What happens at year five? We don't fully know yet. The drug is newer than the hype cycle around it.

Second, the weight loss is real, but a meaningful portion of it can be lean mass (muscle), not just fat. This is a legitimate concern, especially if you're over 50 or already have lower muscle mass. Pairing semaglutide with resistance training and adequate protein intake isn't optional — it's essential if you want the weight you lose to be the right kind.

Third, compounded semaglutide is everywhere right now, and quality control is a genuine problem. FDA-approved formulations like Wegovy have standardized dosing and manufacturing oversight. Compounded versions vary wildly. This is one area where cutting costs could cut your safety margins too.

Fourth, some people don't respond well, or don't respond at all. Non-responders exist. If you've been at the full maintenance dose for three months with minimal weight loss, that's a conversation to have with your prescriber — not a reason to increase the dose on your own.

Who Is Semaglutide Actually Right For?

The FDA-approved indication is adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition (like high blood pressure, type 2 diabetes, or high cholesterol). But the clinical picture is more nuanced than a BMI cutoff.

You're likely a good candidate if:

• You've tried sustained lifestyle intervention without achieving or maintaining clinically meaningful weight loss
• Your weight is driving measurable metabolic risk (elevated fasting glucose, dyslipidemia, elevated blood pressure)
• You understand this is a long-term commitment, not a short-term course
• You're willing to pair it with nutritional changes and exercise — especially resistance training

It's probably not the right starting point if your primary goal is cosmetic weight loss in the single-digit-pound range, or if you have a personal or family history of medullary thyroid carcinoma or MEN2 (multiple endocrine neoplasia syndrome type 2), which are contraindications to GLP-1 agonists.

Risks and Side Effects

The side effect profile is real and worth knowing before you start:

• GI effects (most common): Nausea, vomiting, diarrhea, constipation, and stomach pain — especially during dose escalation. Usually improve over time.
• Decreased appetite (expected, but manageable): Can lead to inadequate protein or caloric intake if you're not deliberate about nutrition.
• Muscle loss: Meaningful in some users, especially without exercise. Track this.
• Pancreatitis: Rare but reported. Severe or persistent abdominal pain warrants immediate medical attention.
• Gallbladder issues: Gallstones and cholecystitis (gallbladder inflammation) are more common with rapid weight loss from any cause, including semaglutide.
• Injection site reactions: Usually minor. Rotating sites helps.
• Thyroid concerns: Animal studies showed C-cell thyroid tumors at high doses. Human relevance is still unclear, but it's a contraindication in those with relevant family history.

Medical supervision isn't just nice-to-have here. It's the mechanism by which side effects get caught and managed before they become reasons to quit — or worse.

How to Get Started with Semaglutide Through Healthspan

Semaglutide is a prescription medication. That means you need a prescriber who knows your full health picture, your labs, your goals, and your risk factors — not just a form you fill out online and a vial that shows up at your door.

Healthspan's GLP-1 Longevity Care protocol is built around exactly that kind of clinical oversight. It includes an initial consultation to review your health history and metabolic baseline, lab work to flag any contraindications or metabolic issues before you start, and ongoing monitoring as you move through the titration schedule. Your dose escalation is guided by your actual response — not just a calendar.

For those who prefer FDA-approved branded options, Healthspan also offers Wegovy Pen with Ongoing Care and Wegovy Pill with Ongoing Care, both with the same clinical framework: not just a prescription, but a protocol. If you're also managing blood sugar or metabolic health more broadly, the SGLT2 Protocol or CGM Metabolic Protocol may be relevant additions your clinician can discuss with you.

If you're ready to find out whether semaglutide is clinically appropriate for you, start with a consultation — that's where the actual protocol begins.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

The standard starting dose of semaglutide for weight loss is 0.25 mg injected once weekly for the first four weeks. This is a tolerance-building dose, not a therapeutic one — you won't see significant weight loss at this level. The purpose is to let your GI system adapt before escalating to higher, more effective doses.

How long does it take to reach the full semaglutide dose?

Following the standard titration schedule, it takes approximately 16 to 17 weeks to reach the maintenance dose of 2.4 mg/week. If you need to extend any step due to side effects, it can take longer — and that's entirely appropriate. Slower titration generally means better tolerability and better long-term adherence.

What should I do if I miss my weekly semaglutide injection?

If fewer than five days have passed since your missed dose, take it as soon as you remember and resume your regular schedule. If five or more days have passed, skip the missed dose and wait until your next scheduled injection day. Never take two doses in one week to make up for a missed one.

Can I stay at a lower semaglutide dose if I'm losing weight?

Yes — if you're achieving meaningful weight loss and tolerating a lower dose well, there's no clinical requirement to push to 2.4 mg. Some people do well at 1.0 or 1.7 mg. The goal is the lowest effective dose that achieves your health targets with acceptable side effects. This is a conversation to have with your prescriber, not a decision to make unilaterally.

How much weight can I expect to lose on semaglutide?

In the STEP 1 clinical trial, participants lost an average of 14.9% of their body weight over 68 weeks at 2.4 mg/week. Individual results vary considerably. Non-responders exist. And weight regain is common after discontinuation, which is why semaglutide is generally considered a long-term treatment, not a short course.

Does it matter what time of day I inject semaglutide?

No — semaglutide can be injected at any time of day, with or without food. What matters most is consistency: inject on the same day each week. Some people find injecting in the evening reduces nausea, since you sleep through the peak absorption window. Experiment in the first few weeks to find what works for your routine.

What happens if I stop taking semaglutide?

Most people regain a significant portion of lost weight after stopping semaglutide. The STEP 4 trial found that participants who discontinued the drug regained roughly two-thirds of their weight loss within one year. This doesn't mean you're stuck on it forever, but it does mean any plan to stop should involve a conversation with your prescriber about how to maintain your results.